Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Prostatic Hyperplasia and CYP3A5[original query] |
---|
The androgen receptor CAG repeat length polymorphism associates with prostate volume in Finnish men with benign prostatic hyperplasia. DNA and cell biology 2008 Feb 27 (2): 109-13. Renko Outi, Savolainen Eeva-Riitta, Loikkanen Ildikó, Paavonen Timo K, Vaarala Markku |
Joint effects of inflammation and androgen metabolism on prostate cancer severity. International journal of cancer. Journal international du cancer 2008 Sep 123 (6): 1385-9. Rebbeck Timothy R, Rennert Hanna, Walker Amy H, Panossian Saarene, Tran Teo, Walker Kyle, Spangler Elaine, Patacsil-Coomes Margerie, Sachdeva Rajeev, Wein Alan J, Malkowicz S Bruce, Zeigler-Johnson Charni |
The influence of UGT2B7, UGT1A8, MDR1, ALDH, ADH, CYP3A4 and CYP3A5 genetic polymorphisms on the pharmacokinetics of silodosin in healthy Chinese volunteers. Drug metabolism and pharmacokinetics 2012 Dec . Wang Z, Xiang Q, Cui Y, Zhao X, Zhou Y |
Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the ?-adrenergic receptor antagonist. The aging male : the official journal of the International Society for the Study of the Aging Male 2017 Aug 1-7. Qian Xiaoqiang, Xu Ding, Liu Hailong, Lin Xiaoling, Yu Yongjiang, Kang Jian, Sheng Xujun, Xu Jianfeng, Zheng Siqun, Xu Danfeng, Qi J |
Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans. European journal of clinical pharmacology 2018 Jun . Kim Kyoung-Ah, Park In-Bae, Park Ji-You |
Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin. Frontiers in pharmacology 2021 10 12 718281. Villapalos-García Gonzalo, Zubiaur Pablo, Navares-Gómez Marcos, Saiz-Rodríguez Miriam, Mejía-Abril Gina, Martín-Vílchez Samuel, Román Manuel, Ochoa Dolores, Abad-Santos Francis |
[Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study]. Urologiia (Moscow, Russia : 1999) 2023 12 (6): 5-13. P Abdullaev Sh, N Shatokhin M, N Tuchkova S, P Abdullaev Sh, V Teodorovich O, B Loran O, A Sychev |
- Page last reviewed:Feb 1, 2024
- Content source: